medigraphic.com
SPANISH

Revista de Nefrología, Diálisis y Trasplante

ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 2

<< Back Next >>

Rev Nefrol Dial Traspl 2020; 40 (2)

Impact of asymptomatic bacteriuria on renal transplantation. retrospective cohort study

Fragale G, Franco R, Magenta M, Karl A, Beitía V, Tisi BM
Full text How to cite this article

Language: Spanish
References: 13
Page: 99-105
PDF size: 189.33 Kb.


Key words:

urinary infection, asymptomatic bacteriuria, bacterial multidrug resistance, kidney transplantion, renal function.

ABSTRACT

Introduction: Asymptomatic bacteriuria (AB) during the first year post-renal transplantation has an incidence higher than 50%. Urinary tract infection (UTI) is the most frequent complication of renal transplantation; its incidence is between 30 and 70 % during the first year. Objective: To analyze the incidence of UTI and AB during the first year post-renal transplantation and their impact on renal function. Methods: Retrospective study in renal transplantation patients older than 18 between January 2006 and December 2017 in our center. Patients who had received combined renal transplantation, lost renal graft during the first year due to surgical complications (thrombosis, allograft rupture) or medical complications (rejection, underlying disease recurrence) were excluded. Results: A study was performed with 161 adult patients who had undergone kidney transplantation. The incidence of UTI and AB during the first year after receiving transplantation was 32% and 25%, respectively. The mean renal function one year after transplantation was as follows: (n=53) Cr 1.36(±0.44) for UTI patients; (n=30) Cr 1.36(±0.41) for AB non-treated patients; (n=11) Cr 1.39(±0.42) for AB treated patients, and (n=90) Cr 1.31(±0.43) p=0.95 for patients not suffering from UTI or AB. The risk of UTI was 55 % for non-treated AB and 57% for treated AB, with RR 0.96 (95% CI: 0.52-1.8). Conclusion: No significant differences in renal function were found in UTI and AB patients one year after transplantation as compared to patients not suffering from these conditions. AB treatment did not reduce UTI risk.


REFERENCES

  1. Parasuraman R, Julian K; AST Infectious DiseasesCommunity of Practice. Urinary tract infectionsin solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):327-36. doi:10.1111/ajt.12124.

  2. Fiorante S, López-Medrano F, Lizasoain M, LaluezaA, Juan RS, Andrés A, et al. Systematic screeningand treatment of asymptomatic bacteriuria in renaltransplant recipients. Kidney Int. 2010;78(8):774-81.doi:10.1038/ki.2010.286.

  3. Bodro M, Sanclemente G, Lipperheide I, Allali M,Marco F, Bosch J, et al. Impact of urinary tractinfections on short-term kidney graft outcome. ClinMicrobiol Infect. 2015;21(12):1104.e1-8. doi:10.1016/j.cmi.2015.07.019.

  4. El Amari EB, Hadaya K, Bühler L, Berney T, RohnerP, Martin PY, et al. Outcome of treated and untreatedasymptomatic bacteriuria in renal transplant recipients.Nephrol Dial Transplant. 2011;26(12):4109-14.doi:10.1093/ndt/gfr198.

  5. Green H, Rahamimov R, Goldberg E, Leibovici L,Gafter U, Bishara J, et al. Consequences of treatedversus untreated asymptomatic bacteriuria in the firstyear following kidney transplantation: retrospectiveobservational study. Eur J Clin Microbiol Infect Dis.2013;32(1):127-31. doi:10.1007/s10096-012-1727-2.

  6. Coussement J, Scemla A, Abramowicz D, Nagler EV,Webster AC. Antibiotics for asymptomatic bacteriuriain kidney transplant recipients. Cochrane DatabaseSyst Rev. 2018;2:CD011357. doi:10.1002/14651858.CD011357.pub2.

  7. Coussement J, Maggiore U, Manuel O, Scemla A,López-Medrano F, Nagler EV, et al. Diagnosis andmanagement of asymptomatic bacteriuria in kidneytransplant recipients: a survey of current practice inEurope. Nephrol Dial Transplant. 2018;33(9):1661-1668. doi:10.1093/ndt/gfy078.

  8. Gołębiewska JE, Dębska-Ślizień A, Rutkowski B.Urinary tract infections during the first year after renaltransplantation: one center’s experience and a reviewof the literature. Clin Transplant. 2014;28(11):1263-70.doi:10.1111/ctr.12465.

  9. van Delden C, Blumberg EA; AST Infectious DiseasesCommunity of Practice. Multidrug resistant gramnegativebacteria in solid organ transplant recipients.Am J Transplant. 2009;9(Suppl 4):S27-34. doi:10.1111/j.1600-6143.2009.02890.x.

  10. Kotagiri P, Chembolli D, Ryan J, Hughes PD,Toussaint ND. Urinary tract infections in thefirst year post-kidney transplantation: potentialbenefits of treating asymptomatic bacteriuria.Transplant Proc. 2017;49(9):2070-2075. doi:10.1016/j.transproceed.2017.07.008.

  11. Moradi M, Abbasi M, Moradi A, Boskabadi A,Jalali A. Effect of antibiotic therapy on asymptomaticbacteriuria in kidney transplant recipients. Urol J.2005;2(1):32-5.

  12. Origüen J, López-Medrano F, Fernández-Ruiz M,Polanco N, Gutiérrez E, González E, et al. Shouldasymptomatic bacteriuria be systematically treated inkidney transplant recipients? Results from a randomizedcontrolled trial. Am J Transplant. 2016;16(10):2943-2953. doi:10.1111/ajt.13829.

  13. Sabé N, Oriol I, Melilli E, Manonelles A, Bestard O,Polo C, et al. Antibiotic Treatment versus no treatmentfor asymptomatic bacteriuria in kidney transplantrecipients: a multicenter randomized trial. Open ForumInfect Dis. 2019;6(6):ofz243. doi:10.1093/ofid/ofz243.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Nefrol Dial Traspl. 2020;40